Epidemiological characteristics and genetic structure of blaNDM-1 in non-baumannii Acinetobacter spp. in China

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 9, 2012, Pages 2114-2122

  Fu, Ying ^a   Du, Xiaoxing ^a   Ji, Jingshu ^a   Chen, Yan ^a   Jiang, Yan ^a   Yu, Yunsong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Epidemiology; NDM 1 metallo lactamase; Transposon structure

Indexed keywords

BACTERIAL PROTEIN; BLANDM 1 PROTEIN; RIBOSOME DNA; RNA 16S; RNA 23S; RNA POLYMERASE BETA SUBUNIT; UNCLASSIFIED DRUG;

ACINETOBACTER; ACINETOBACTER BAYLYI; ACINETOBACTER HAEMOLYTICUS; ACINETOBACTER JOHNSONII; ACINETOBACTER JUNII; ACINETOBACTER LWOFFII; ACINETOBACTER PITTII; ADULT; AGED; AMPLIFIED RIBOSOMAL DNA RESTRICTION ANALYSIS; ARTICLE; CHILD; CHINA; CLINICAL ARTICLE; CONJUGATION; ELECTROTRANSFORMATION; ESCHERICHIA COLI; FEMALE; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; HUMAN; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SCHOOL CHILD; SEQUENCE ANALYSIS; SOUTHERN BLOTTING;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADULT; AGED; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; BLOTTING, SOUTHERN; CHILD; CHINA; DNA, BACTERIAL; DNA, RIBOSOMAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84865373918     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks192     Document Type: Article

References (41)

1. Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43 Suppl 2: S43-8.
2. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46: 1254-63.
3. Murray CK, Hospenthal DR. Acinetobacter infection in the ICU. Crit Care Clin 2008; 24: 237-48, vii.
4. Seifert H, Dijkshoorn L. Overview of the microbial characteristics, taxonomy, and epidemiology of Acinetobacter. In: Bergogne-Berezin E, ed. Acinetobacter Biology and Pathogenesis. New York: Springer, 2008; 19-45.
5. Turton JF, Shah J, Ozongwu C et al. Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species. J Clin Microbiol 2010; 48: 1445-9.
6. Higgins PG, Lehmann M, Wisplinghoff H et al. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol 2010; 48: 4592-4.
7. La Scola B, Gundi VA, Khamis A et al. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 2006; 44: 827-32.
8. Espinal P, Roca I, Vila J. Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter. Future Microbiol 2011; 6: 495-511.
9. Wang H, Guo P, Sun H et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 2007; 51: 4022-8.
10. Scott P, Deye G, Srinivasan A et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007; 44: 1577-84.
11. Quinteira S, Grosso F, Ramos H et al. Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital. Antimicrob Agents Chemother 2007; 51: 3465-6.
12. Lee YT, Kuo SC, Chiang MC et al. Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii. Antimicrob Agents Chemother 2012; 56: 1124-7.
13. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-82.
14. Walsh TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 2010; 36 Suppl 3: S8-14.
15. Poirel L, Lagrutta E, Taylor P et al. Emergence of metallo-b-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother 2010; 54: 4914-6.
16. Ho PL, Lo WU, Yeung MK et al. Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrugresistant Escherichia coli strain isolated in Hong Kong. PLoS One 2011; 6: e17989.
17. Bogaerts P, Bouchahrouf W, de Castro RR et al. Emergence of NDM-1-producing Enterobacteriaceae in Belgium. Antimicrob Agents Chemother 2011; 55: 3036-8.
18. Zarfel G, Hoenigl M, Leitner E et al. Emergence of New Delhi metallo-b-lactamase, Austria. Emerg Infect Dis 2011; 17: 129-30.
19. Mochon AB, Garner OB, Hindler JA et al. New Delhi metallo-b-lactamase (NDM-1)-producing Klebsiella pneumoniae: case report and laboratory detection strategies. J Clin Microbiol 2011; 49: 1667-70.
20. Wu HS, Chen TL, Chen IC et al. First identification of a patient colonized with Klebsiella pneumoniae carrying blaNDM-1 in Taiwan. J Chin Med Assoc 2010; 73: 596-8.
21. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
22. Poirel L, Dortet L, Bernabeu S et al. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother 2011; 55: 5403-7.
23. Lai CC, Lin TL, Tseng SP et al. Pelvic abscess caused by New Delhi metallo-b-lactamase-1-producing Klebsiella oxytoca in Taiwan in a patient who underwent renal transplantation in China. Diagn Microbiol Infect Dis 2011; 71: 474-5.
24. Chen Z, Qlu S, Wang Y et al. Coexistence of blaNDM-1 with the prevalent blaOXA23 and blaIMP in pan-drug resistant Acinetobacter baumannii isolates in China. Clin Infect Dis 2011; 52: 692-3.
25. Chen Y, Zhou Z, Jiang Y et al. Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother 2011; 66: 1255-9.
26. Turton JF, Woodford N, Glover J et al. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 2006; 44: 2974-6.
27. Chang HC, Wei YF, Dijkshoorn L et al. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005; 43: 1632-9.
28. Nemec A, Musilek M, Sedo O et al. Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively. Int J Syst Evol Microbiol 2010; 60: 896-903.
29. Nemec A, Krizova L, Maixnerova M et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 2011; 162: 393-404.
30. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
31. Andrews JM. BSAC Methods for Antimicrobial Susceptibility Testing, Version 9.1 March 2010. http://www.bsac.org.uk/Resources/BSAC/ Version_9.1_March_2010_final.pdf (22 March 2011, date last accessed).
32. Wyeth Pharmaceuticals. Tygacil Product Insert. http://www.tygacil. com (19 December 2006, date last accessed).
33. Hunter SB, Vauterin P, Lambert-Fair MA et al. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol 2005; 43: 1045-50.
34. Pfeifer Y, Wilharm G, Zander E et al. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother 2011; 66: 1998-2001.
35. Chen Y, Cui Y, Pu F et al. Draft genome sequence of an Acinetobacter genomic species 3 strain harboring a blaNDM-1 gene. J Bacteriol 2012; 194: 204-5.
36. Espinal P, Seifert H, Dijkshoorn L et al. Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect 2011; doi:10.1111/ j.1469-0691.2011.03696.x.
37. Perez F, Hujer AM, Hujer KM et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51: 3471-84.
38. Martinez JL. Antibiotics and antibiotic resistance genes in natural environments. Science 2008; 321: 365-7.
39. D'Costa VM, McGrann KM, Hughes DW et al. Sampling the antibiotic resistome. Science 2006; 311: 374-7.
40. Zheng B, Tan S, Gao J et al. An unexpected similarity between antibiotic-resistant NDM-1 and b-lactamase II from Erythrobacter litoralis. Protein Cell 2011; 2: 250-8.
41. Sekizuka T, Matsui M, Yamane K et al. Complete sequencing of the blaNDM-1-positive IncA/C plasmid from Escherichia coli ST38 isolate suggests a possible origin fromplant pathogens. PLoS One 2011; 6: e25334.